{
    "2021-12-29": [
        [
            {
                "time": "",
                "original_text": "十家公司年内获上千家机构调研 迈瑞医疗、汇川技术最受关注",
                "features": {
                    "keywords": [
                        "机构调研",
                        "迈瑞医疗",
                        "汇川技术"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗设备",
                        "工业自动化"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业投资策略：关注政策扰动下的个股机会",
                "features": {
                    "keywords": [
                        "医药行业",
                        "政策扰动",
                        "个股机会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "顶层设计出台——“十四五”医疗装备规划，七大领域将受益！",
                "features": {
                    "keywords": [
                        "顶层设计",
                        "十四五",
                        "医疗装备",
                        "七大领域"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗设备"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "西南证券医药2022年度策略：未来医药估值有望均衡，“穿越医保”和“疫情脱敏”是两条核心主线",
                "features": {
                    "keywords": [
                        "医药估值",
                        "均衡",
                        "穿越医保",
                        "疫情脱敏"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "《“十四五”医疗装备产业发展规划》发布 关注7大重点领域",
                "features": {
                    "keywords": [
                        "十四五",
                        "医疗装备",
                        "发展规划",
                        "7大重点领域"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗设备"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物：关注年报业绩预告有望高增长公司",
                "features": {
                    "keywords": [
                        "医药生物",
                        "年报",
                        "业绩预告",
                        "高增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}